An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present)
Expert Opin Ther Pat. 2026 Jun 23. doi: 10.1080/13543776.2026.2694586. Online ahead of print.ABSTRACTINTRODUCTION: Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a conserved CMGC serine/threonine kinase with an autophosphorylation-dependent activation mechanism. As a dosag

